GL1X · GenesisL1 explorer

Research workbench

GSK3B in complex with inhibitor

Analyse GSK3B in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ACH
Type
protein
Length
700 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.1, 2.7.11.26
UniProt
P49841
Ligands
KDI
Pockets
9 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGlycogen synthase kinase-3 beta (EC 2.7.11.1, 2.7.11.26)protein35034% helix, 19% strandP49841

Ligands and binding sites

  • KDI · 3-amino-N-(3-methoxypropyl)-6-{4-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}pyrazine-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19980.800.8164KDI
210990.800.8174KDI
31070.750.9626empty
4810.430.8022empty
5920.420.7819empty

Interfaces

1 interface between chains.

  • A–B · 1442 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4ACH · GSK3b in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.